top of page
Buscar

Fulbright and EMBO fund collaboration with Baker lab

  • Benjamí
  • 29 sept 2022
  • 1 Min. de lectura

Benjamí has spent a 3-month sabbatical in David Baker's lab, a world-reference in protein design, to establish collaborations on conditionally-activated biotherapeutics and new systems for drug transport into the brain.



ree



 
 

Encabezado 1

Chemical & Synthetic Biology
for Biotherapeutics

Challenging Brain Diseases

ChemSynBio logo oficial_transparente.png
European_Research_Council_logo.svg.png
bottom of page